These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22801290)

  • 1. The effects of ziprasidone on prefrontal and amygdalar activation in manic youth with bipolar disorder.
    Schneider MR; Adler CM; Whitsel R; Weber W; Mills NP; Bitter SM; Eliassen J; Strakowski SM; DelBello MP
    Isr J Psychiatry Relat Sci; 2012; 49(2):112-20. PubMed ID: 22801290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofunctional Differences Among Youth With and at Varying Risk for Developing Mania.
    Welge JA; Saliba LJ; Strawn JR; Eliassen JC; Patino LR; Adler CM; Weber W; Schneider MR; Barzman DH; Strakowski SM; DelBello MP; McNamara RK
    J Am Acad Child Adolesc Psychiatry; 2016 Nov; 55(11):980-989. PubMed ID: 27806866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.
    Potkin SG; Keck PE; Segal S; Ice K; English P
    J Clin Psychopharmacol; 2005 Aug; 25(4):301-10. PubMed ID: 16012271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.
    Keck PE; Versiani M; Potkin S; West SA; Giller E; Ice K;
    Am J Psychiatry; 2003 Apr; 160(4):741-8. PubMed ID: 12668364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofunctional effects of quetiapine in patients with bipolar mania.
    Davis AK; DelBello MP; Eliassen J; Welge J; Blom TJ; Fleck DE; Weber WA; Jarvis KB; Rummelhoff E; Strakowski SM; Adler CM
    Bipolar Disord; 2015 Jun; 17(4):444-9. PubMed ID: 25359589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder.
    Findling RL; Cavuş I; Pappadopulos E; Vanderburg DG; Schwartz JH; Gundapaneni BK; DelBello MP
    J Child Adolesc Psychopharmacol; 2013 Oct; 23(8):545-57. PubMed ID: 24111980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder.
    Suppes T; McElroy SL; Sheehan DV; Hidalgo RB; Cosgrove VE; Gwizdowski IS; Feldman NS
    J Clin Psychiatry; 2014 Jan; 75(1):77-84. PubMed ID: 24345758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of carbamazepine on prefrontal activation in manic youth with bipolar disorder.
    Schneider MR; Klein CC; Weber W; Bitter SM; Elliott KB; Strakowski SM; Adler CM; DelBello MP
    Psychiatry Res; 2014 Sep; 223(3):268-70. PubMed ID: 25035298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, Safety, and Tolerability of Flexibly Dosed Ziprasidone in Children and Adolescents with Mania in Bipolar I Disorder: A Randomized Placebo-Controlled Replication Study.
    Findling RL; Atkinson S; Bachinsky M; Raiter Y; Abreu P; Ianos C; Chappell P
    J Child Adolesc Psychopharmacol; 2022 Apr; 32(3):143-152. PubMed ID: 35394365
    [No Abstract]   [Full Text] [Related]  

  • 10. Ziprasidone in bipolar disorder.
    Versiani M
    Expert Opin Pharmacother; 2006 Jun; 7(9):1221-8. PubMed ID: 16732708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial functioning and health-related quality of life in children and adolescents treated with open-label ziprasidone for bipolar mania, schizophrenia, or schizoaffective disorder.
    Stewart M; DelBello MP; Versavel M; Keller D
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):635-40. PubMed ID: 20035581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.
    Bowden CL; Vieta E; Ice KS; Schwartz JH; Wang PP; Versavel M
    J Clin Psychiatry; 2010 Feb; 71(2):130-7. PubMed ID: 20122373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study.
    DelBello MP; Cecil KM; Adler CM; Daniels JP; Strakowski SM
    Neuropsychopharmacology; 2006 Jun; 31(6):1264-73. PubMed ID: 16292323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Practical aspects of the use of ziprasidone in schizophrenia].
    Ochedzan D; Jarema M
    Psychiatr Pol; 2010; 44(6):881-93. PubMed ID: 21449170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using oral ziprasidone effectively: the food effect and dose-response.
    Citrome L
    Adv Ther; 2009 Aug; 26(8):739-48. PubMed ID: 19669631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and efficacy of ziprasidone in subpopulations of patients with bipolar mania.
    Keck PE; Versiani M; Warrington L; Loebel AD; Horne RL
    J Clin Psychiatry; 2009 Jun; 70(6):844-51. PubMed ID: 19573482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary functional magnetic resonance imaging study of prefrontal-amygdalar activation changes in adolescents with bipolar depression treated with lamotrigine.
    Chang KD; Wagner C; Garrett A; Howe M; Reiss A
    Bipolar Disord; 2008 May; 10(3):426-31. PubMed ID: 18402630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder.
    DelBello MP; Versavel M; Ice K; Keller D; Miceli J
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):491-9. PubMed ID: 18928413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission.
    Ketter TA; Agid O; Kapur S; Loebel A; Siu CO; Romano SJ
    J Psychiatr Res; 2010 Jan; 44(1):8-14. PubMed ID: 19699488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS; Vanderburg DG; Karayal ON; Kolluri S; Bachinsky M; Cavus I
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.